Evidence map›Paper›PMID 27139897›Full record

ArticlePediatric nephrology (Berlin, Germany)2016

CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations.

Anna Lorenzin, Francesco Garzotto, Alberta Alghisi, Mauro Neri, Dario Galeano, Stefania Aresu, Antonello Pani, Enrico Vidal, Zaccaroa Ricci, Luisa Murer and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Meropenem extraction by ex vivo extracorporeal life support circuits.The journal of extra-corporeal technology · 2023
    Article
  6. Article
  7. Neonatal fluid overload-ignorance is no longer bliss.Pediatric nephrology (Berlin, Germany) · 2023
    Review
  8. Remdesivir and GS-441524 Extraction by Ex Vivo Extracorporeal Life Support Circuits.ASAIO journal (American Society for Artificial Internal Organs : 1992) · 2022
    Article
  9. Article
  10. Review
  11. Pediatric acute kidney injury: new advances in the last decade.Kidney research and clinical practice · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Continuous Renal Replacement Therapy: Forty-year Anniversary.The International journal of artificial organs · 2017
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Anna LorenzinInternational Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy.
Francesco GarzottoInternational Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy.
Alberta AlghisiDepartment of Immunology and Blood Transfusions, San Bortolo Hospital, Vicenza, Italy.
Mauro NeriInternational Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy.
Dario GaleanoInternational Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy.
Stefania AresuNephrology, Dialysis and Transplantation "G. Brotzu" Hospital, Cagliari, Italy.
Antonello PaniNephrology, Dialysis and Transplantation "G. Brotzu" Hospital, Cagliari, Italy.
Enrico VidalNephrology, Dialysis and Transplant Unit, Department of Woman's and Child's Health, Hospital and University of Padova, Padova, Italy.
Zaccaroa RicciDepartment of Cardiology and Cardiac Surgery, Pediatric Cardiac Intensive Care Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Luisa MurerNephrology, Dialysis and Transplant Unit, Department of Woman's and Child's Health, Hospital and University of Padova, Padova, Italy.
Stuart L GoldsteinCenter for Acute Care Nephrology, Cincinnati Children's Hospital, Cincinnati, OH, USA. stuart.goldstein@cchmc.org.
Claudio RoncoInternational Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy.
International Renal Research Institute of Vicenza · ITAzienda Ospedaliera G. Brotzu · ITBambino Gesù Children's Hospital · ITUniversity of Padua · ITCincinnati Children's Hospital Medical Center · USOspedale San Bortolo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe CARdiorenal PEDIatric EMergency (CARPEDIEM) machine was originally designed to perform only continuous venovenous hemofiltration (CVVH) in neonatal and pediatric patients. In some cases, adequate convective clearance may not be reached because of a limited blood flow. In such conditions, the application of diffusive clearance [continuous venovenous hemodialysis (CVVHD)] would help optimize blood purification. In this study, the CARPEDIEM™ machine was modified to enable the circulation of dialysis through the filter allowing testing of the performance of CARPEDIEM™ machine in CVVHD.

methodsThree different polyethersulfone hemodialyzers (surface area = 0.1 m(2), 0.2 m(2), and 0.35 m(2), respectively) were tested in vitro with a scheduled combination of plasma flow rates (Qp = 10-20-30 ml/min) and dialysis fluid flow rate (Qd = 5-10-15 ml/min). Three sessions were performed in co-current and one in counter-current configuration (as control) for each filter size. Clearance was measured from the blood and dialysate sides and results with mass balance error greater than 5 % were discarded.

resultsUrea and creatinine clearances for each plasma/dialysate combination are reported: clearance increase progressively for every filter proportionally to plasma flow rates. Similarly, clearances increase progressively with dialysate flow rates at a given plasma flow. The clearance curve tends to present a steep increase for small increases in plasma flow in the range below 10 ml/min, while the curve tends to plateau for values averaging 30 ml/min. As expected, the plateau is reached earlier with the smaller filter showing the effect of membrane surface-area limitation. At every plasma flow, the effect of dialysate flow increase is evident and well defined, showing that saturation of effluent was not achieved completely in any of the experimental conditions explored. No differences (p > 0.05 for all values) were obtained in experiments using whole blood instead of plasma or using co-current versus counter-current dialysate flow configuration.

conclusionsAlthough plasma flow and filter surface give an important contribution to the level of clearance urea and creatinine, it appears evident that dialysate flow plays an essential role in the blood purification process, justifying the use of CVVHD versus CVVH in case of high dialysis dose requirement and/or limited blood flow rate.

Indexed as

Acute Kidney InjuryChildCreatinineDialysis SolutionsEquipment DesignHemofiltrationHumansPolymersSulfonesUltrafiltrationUreaCreatinineDialysis Solutionspolyether sulfonePolymersSulfonesUreaAKICRRTCVVHDNeonatePediatric RRT

Identifiers

PMID27139897
OpenAlexW2345037372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.